NCT07086937View on ClinicalTrials.gov

Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Nitazoxanide

Children were given nitazoxanide, PPI, and clarithromycin for 14 days.

DRUG

Metronidazole

Children received MTZ, PPI, and clarithromycin for 14 days.

DRUG

PPI

Children were given omeprazole for 14 days.

DRUG

Clarithromycin

Children were given clarithromycin for 14 days.

Trial Locations (1)

74700

Ziauddin University Hospital, Karachi

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER

NCT07086937 - Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children | Biotech Hunter | Biotech Hunter